AAAAAA
Results: 1-25/26
Authors:
Panaccione, R
Fedorak, RN
Feagan, B
Steinhart, H
Wild, G
Baron, D
Bernstein, C
Bitton, A
Buckley, A
Croitoru, K
Enns, R
Greenberg, G
Hassard, P
Semlacher, E
Sutherland, L
Tavenor, A
Tourigny, M
Walli, E
Williams, N
Citation: R. Panaccione et al., Canadian Association of Gastroenterology clinical practice guidelines: Theuse of infliximab in Crohn's disease, CAN J GASTR, 15(6), 2001, pp. 367-370
Authors:
Romagnuolo, J
Fedorak, RN
Dias, VC
Bamforth, F
Teltscher, M
Citation: J. Romagnuolo et al., Hyperhomocysteinemia and inflammatory bowel disease: Prevalence and predictors in a cross-sectional study, AM J GASTRO, 96(7), 2001, pp. 2143-2149
Authors:
Fedorak, RN
Citation: Rn. Fedorak, Benefits of membership, CAN J GASTR, 14(3), 2000, pp. 169-170
Authors:
Fedorak, RN
Citation: Rn. Fedorak, Assessment of medical journal quality, CAN J GASTR, 14(2), 2000, pp. 89-90
Authors:
Fedorak, RN
Citation: Rn. Fedorak, Economic impact of digestive, nutritional and oral diseases in Canada, CAN J GASTR, 14(1), 2000, pp. 13-14
Authors:
Feagan, BG
Fedorak, RN
Irvine, EJ
Wild, G
Sutherland, L
Steinhart, AH
Greenberg, GR
Koval, J
Wong, CJ
Hopkins, M
Hanauer, SB
McDonald, JWD
Citation: Bg. Feagan et al., A comparison of methotrexate with placebo for the maintenance of remissionin Crohn's disease, N ENG J MED, 342(22), 2000, pp. 1627-1632
Authors:
Schreiber, S
Fedorak, RN
Nielsen, OH
Wild, G
Williams, CN
Nikolaus, S
Jacyna, M
Lashner, BA
Gangl, A
Rutgeerts, P
Isaacs, K
Van Deventer, SJH
Koningsberger, JC
Cohard, M
LeBeaut, A
Hanauer, SB
Citation: S. Schreiber et al., Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease, GASTROENTY, 119(6), 2000, pp. 1461-1472
Authors:
Fedorak, RN
Gangl, A
Elson, CO
Rutgeerts, P
Schreiber, S
Wild, G
Hanauer, SB
Kilian, A
Cohard, M
LeBeaut, A
Feagan, B
Citation: Rn. Fedorak et al., Recombinant human interleukin 10 in the treatment of patients with mild tomoderately active Crohn's disease, GASTROENTY, 119(6), 2000, pp. 1473-1482
Authors:
Madsen, KL
Doyle, JS
Tavernini, MM
Jewell, LD
Rennie, RP
Fedorak, RN
Citation: Kl. Madsen et al., Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice, GASTROENTY, 118(6), 2000, pp. 1094
Authors:
Taylor, DE
Fedorak, RN
Sherburne, R
Citation: De. Taylor et al., Antigenic mimicry between Helicobacter pylori and gastric mucosa: Failure to implicate heat-shock protein Hsp60 using immunoelectron microscopy, HELICOBACT, 4(3), 1999, pp. 148-153
Authors:
Madsen, KL
Malfair, D
Gray, D
Doyle, JS
Jewell, LD
Fedorak, RN
Citation: Kl. Madsen et al., Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora, INFLAMM B D, 5(4), 1999, pp. 262-270
Authors:
Fedorak, RN
Citation: Rn. Fedorak, Process of nomination for the CAG board of directors and committees, CAN J GASTR, 13(9), 1999, pp. 708-709
Authors:
Fedorak, RN
Sharkey, K
Citation: Rn. Fedorak et K. Sharkey, Research funding by the CAG reaches its highest level ever!, CAN J GASTR, 13(7), 1999, pp. 542-544
Authors:
Fedorak, RN
Citation: Rn. Fedorak, CAG members receive prestigious Janssen awards, CAN J GASTR, 13(6), 1999, pp. 449-450
Authors:
Fedorak, RN
Citation: Rn. Fedorak, Canadian Institutes of Health Research: Should there be an institute for digestive sciences?, CAN J GASTR, 13(5), 1999, pp. 367-369
Authors:
Fedorak, RN
Citation: Rn. Fedorak, 1999 Visiting Research Professorship and Young Investigator Award - The 1999 CAG Visiting Research Professorship - Dr Lloyd R Sutherland, CAN J GASTR, 13(4), 1999, pp. 289-290
Authors:
Fedorak, RN
Citation: Rn. Fedorak, 1999 Visiting Research Professorship and Young Investigator Award - The 1999 CAG Young Investigator Award - Dr Keith A Sharkey, CAN J GASTR, 13(4), 1999, pp. 290-290
Authors:
Fedorak, RN
Citation: Rn. Fedorak, Growth of the Canadian Association of Gastroenterology: Controlled, effective and impressive, CAN J GASTR, 13(3), 1999, pp. 191-193
Authors:
Fedorak, RN
Citation: Rn. Fedorak, An update and a revisit, CAN J GASTR, 13(2), 1999, pp. 105-106
Authors:
Fedorak, RN
Citation: Rn. Fedorak, The success of Gastro '99 and the first CDDW of the millennium, CAN J GASTR, 13(10), 1999, pp. 795-797
Authors:
Fedorak, RN
Citation: Rn. Fedorak, Recertification in gastroenterology - It's true, and it's here!, CAN J GASTR, 13(1), 1999, pp. 13-14
Authors:
Barkun, AN
Cockeram, AW
Plourde, V
Fedorak, RN
Citation: An. Barkun et al., Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding, ALIM PHARM, 13(12), 1999, pp. 1565-1584
Authors:
Pluhator-Murton, MM
Fedorak, RN
Audette, RJ
Marriage, BJ
Yatscoff, RW
Grarulich, LM
Citation: Mm. Pluhator-murton et al., Trace element contamination of total parenteral nutrition. 1. Contributionof component solutions, J PARENT EN, 23(4), 1999, pp. 222-227
Authors:
Pluhator-Murton, MM
Fedorak, RN
Audette, RJ
Marriage, BJ
Yatscoff, RW
Gramlich, LM
Citation: Mm. Pluhator-murton et al., Trace element contamination of total parenteral nutrition. 2. Effect of storage duration and temperature, J PARENT EN, 23(4), 1999, pp. 228-232
Authors:
Sandborn, WJ
Tremaine, WJ
Wolf, DC
Targan, SR
Sninsky, CA
Sutherland, LR
Hanauer, SB
McDonald, JWD
Feagan, BG
Fedorak, RN
Isaacs, KL
Pike, MG
Mays, DC
Lipsky, JJ
Gordon, S
Kleoudis, CS
Murdock, RH
Citation: Wj. Sandborn et al., Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease, GASTROENTY, 117(3), 1999, pp. 527-535